The medical software company closes the care gap in reproductive health by providing clinical decision support and virtual care pathways. /PRNewswire/ -- LEVY Health, an innovator in the field of reproductive health technology, has raised $4.5 million led by San Francisco -based venture firm XYZ Venture Capital, with additional participation from Atlantic Labs and Possible Ventures.
The new funding will be used to integrate LEVY Health's virtual care pathways, which reduce time to treatment from years to weeks, with electronic medical record software. It will also fuel the company's growth across women's health and reproductive care, with solutions for fertility clinics, fertility benefit providers, laboratories, and biopharma companies. Tackling the Reproductive Care Gap Studies show that 80-85% of women are diagnosed with an endocrine disorder at least once in their lifetime, and 20% of individuals in the U.
S. struggle with fertility problems. However, the shortage of women's healthcare providers and reproductive endocrinologists (REIs) leaves millions of patients facing long, excruciating wait times for diagnoses and treatment.
LEVY Health bridges this gap by applying smart algorithms, enabling precision diagnostics and personalized recommendations for treatment. Founded by three women in 2021, LEVY Health has developed clinical decision support based on medical guidelines, clinical studies, and lab data. The company's software combines health information with lab results,.